130 related articles for article (PubMed ID: 22914035)
1. Use of a keratin-based wound dressing in the management of wounds in a patient with recessive dystrophic epidermolysis bullosa.
Kirsner RS; Cassidy S; Marsh C; Vivas A; Kelly RJ
Adv Skin Wound Care; 2012 Sep; 25(9):400-3. PubMed ID: 22914035
[TBL] [Abstract][Full Text] [Related]
2. Use of a keratin-based hydrogel in the management of recessive dystrophic epidermolysis bullosa.
Than MP; Smith RA; Cassidy S; Kelly R; Marsh C; Maderal A; Kirsner RS
J Dermatolog Treat; 2013 Aug; 24(4):290-1. PubMed ID: 22208480
[TBL] [Abstract][Full Text] [Related]
3. Participatory co-design of patient-reported outcome indicators and N-of-1 evaluation of a dressing glove for Epidermolysis bullosa.
Graham T; Sooriah S; Box R; Gage H; Williams P; Clemett V; Grocott P
J Wound Care; 2020 Dec; 29(12):751-762. PubMed ID: 33320744
[TBL] [Abstract][Full Text] [Related]
4. Purified type I collagen wound matrix improves chronic wound healing in patients with recessive dystrophic epidermolysis bullosa.
Gorell ES; Leung TH; Khuu P; Lane AT
Pediatr Dermatol; 2015; 32(2):220-5. PubMed ID: 25557742
[TBL] [Abstract][Full Text] [Related]
5. Keratin gel in the management of Epidermolysis bullosa.
Denyer J; Marsh C; Kirsner RS
J Wound Care; 2015 Oct; 24(10):446-50. PubMed ID: 26488735
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for recessive dystrophic epidermolysis bullosa.
Titeux M; Pendaries V; Hovnanian A
Dermatol Clin; 2010 Apr; 28(2):361-6, xii. PubMed ID: 20447504
[TBL] [Abstract][Full Text] [Related]
7. Using honey to heal a chronic wound in a patient with epidermolysis bullosa.
Hon J
Br J Nurs; 2005 Oct 27-Nov 9; 14(19):S4-5, S8, S10 passim. PubMed ID: 16315361
[TBL] [Abstract][Full Text] [Related]
8. Using a dermal skin substitute in the treatment of chronic wounds secondary to recessive dystrophic epidermolysis bullosa: a case series.
Sibbald RG; Zuker R; Coutts P; Coelho S; Williamson D; Queen D
Ostomy Wound Manage; 2005 Nov; 51(11):22-46. PubMed ID: 16319445
[TBL] [Abstract][Full Text] [Related]
9. Inpatient management of children with recessive dystrophic epidermolysis bullosa: A review.
Li AW; Prindaville B; Bateman ST; Gibson TE; Wiss K
Pediatr Dermatol; 2017 Nov; 34(6):647-655. PubMed ID: 28944966
[TBL] [Abstract][Full Text] [Related]
10. "Sporadic" dystrophic epidermolysis bullosa: a new dominant or mitis recessive mutation?
Vaccaro M; Moretti G; Guarneri F; Cannavò S; Magaudda L
Eur J Dermatol; 2000 Aug; 10(6):436-8. PubMed ID: 10980463
[TBL] [Abstract][Full Text] [Related]
11. [Dystrophic epidermolysis bullosa: surgical treatment of advanced hand deformities].
Siepe P; Roessing C; Safi A
Handchir Mikrochir Plast Chir; 2002 Sep; 34(5):307-13. PubMed ID: 12494382
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa.
Yan WF; Murrell DF
Dermatol Clin; 2010 Apr; 28(2):367-70, xii. PubMed ID: 20447505
[TBL] [Abstract][Full Text] [Related]
13. [Epidermolysis bullosa hereditaria dystrophica mutilans Hallopeau-Siemens--a complex problem].
Spitz C; Rösslein R
Handchir Mikrochir Plast Chir; 1998 Mar; 30(2):71-81. PubMed ID: 9592693
[TBL] [Abstract][Full Text] [Related]
14. Topical management of a subclavian catheter in a patient with epidermolysis bullosa.
Watterworth B; Simione D
Ostomy Wound Manage; 1992 Mar; 38(2):18-21. PubMed ID: 1558631
[No Abstract] [Full Text] [Related]
15. Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations.
von Bartenwerffer W; Has C; Arin MJ; Tantcheva-Poór I; Kreuter A; Kremer K; Arshah T; Hoffmann M; Eming SA; Kohlhase J; Krieg T; Bruckner-Tuderman L; Hartmann K
Eur J Dermatol; 2011; 21(2):170-2. PubMed ID: 21382783
[TBL] [Abstract][Full Text] [Related]
16. Dystrophic epidermolysis bullosa with one dominant and one recessive mutation of the COL7A1 gene in a child with deafness.
Weinel S; Lucky AW; Uitto J; Pfendner EG; Choo D
Pediatr Dermatol; 2008; 25(2):210-4. PubMed ID: 18429782
[TBL] [Abstract][Full Text] [Related]
17. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.
Yamada M; Hatta N; Sogo K; Komura K; Hamaguchi Y; Takehara K
Dermatol Surg; 2004 Nov; 30(11):1424-9. PubMed ID: 15522026
[TBL] [Abstract][Full Text] [Related]
18. [Localised de novo dominant dystrophic epidermolysis bullosa].
Bursztejn AC; Pinault AL; Le Louarn Y; Lacour JP; Charlesworth A; Meneguzzi G; Truchetet F
Ann Dermatol Venereol; 2008 Mar; 135(3):195-9. PubMed ID: 18374850
[TBL] [Abstract][Full Text] [Related]
19. Natural gene therapy in dystrophic epidermolysis bullosa.
van den Akker PC; Nijenhuis M; Meijer G; Hofstra RM; Jonkman MF; Pasmooij AM
Arch Dermatol; 2012 Feb; 148(2):213-6. PubMed ID: 22004882
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in 3 patients with recessive dystrophic epidermolysis bullosa.
Hasegawa T; Suga Y; Mizoguchi M; Ikeda S; Ogawa H; Kubo K; Matsui H; Kagawa S; Kuroyanagi Y
J Am Acad Dermatol; 2004 May; 50(5):803-4. PubMed ID: 15097978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
